tiprankstipranks
Trending News
More News >
Shanghai Chicmax Cosmetics Co., Ltd. Class H (HK:2145)
:2145
Hong Kong Market
Advertisement

Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) AI Stock Analysis

Compare
0 Followers

Top Page

HK:2145

Shanghai Chicmax Cosmetics Co., Ltd. Class H

(2145)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
HK$94.00
▲(2.34% Upside)
Shanghai Chicmax Cosmetics Co., Ltd. has a strong financial foundation with robust revenue growth and profitability, contributing positively to the overall score. However, technical analysis indicates bearish momentum, which weighs down the score. The valuation suggests the stock is relatively expensive, but the dividend yield offers some compensation. The absence of earnings call and corporate events data means these factors do not influence the score.

Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) vs. iShares MSCI Hong Kong ETF (EWH)

Shanghai Chicmax Cosmetics Co., Ltd. Class H Business Overview & Revenue Model

Company DescriptionShanghai Chicmax Cosmetics Co., Ltd. is a leading player in the cosmetics industry, specializing in the development, production, and distribution of a diverse range of beauty products. The company operates primarily in the personal care and cosmetic sectors, offering a wide array of products including skincare, makeup, and hair care solutions. Chicmax is known for its innovative approaches to product formulation and packaging, catering to both domestic and international markets.
How the Company Makes MoneyChicmax generates revenue through multiple key streams including direct sales of its cosmetics and skincare products through retail channels, e-commerce platforms, and partnerships with beauty retailers. The company also benefits from private label services where it manufactures products for other brands, thus diversifying its income sources. Furthermore, strategic collaborations with distributors and influencers in the beauty industry enhance its market reach and brand visibility, driving sales growth. The company's focus on research and development allows for the continuous introduction of new products, keeping its offerings fresh and appealing to a broad consumer base.

Shanghai Chicmax Cosmetics Co., Ltd. Class H Financial Statement Overview

Summary
Shanghai Chicmax Cosmetics Co., Ltd. demonstrates strong financial performance with robust revenue growth, high profitability margins, and low leverage. The company effectively utilizes its equity to generate returns, although there is room to improve cash conversion efficiency. Overall, the financial statements reflect a well-managed company with a positive growth outlook and financial stability.
Income Statement
85
Very Positive
Shanghai Chicmax Cosmetics Co., Ltd. shows strong revenue growth with a TTM increase of 4.27%. The company maintains high gross and net profit margins at 75.22% and 11.50%, respectively, indicating robust profitability. EBIT and EBITDA margins are also healthy, reflecting efficient operations. Overall, the income statement reflects a positive growth trajectory and strong profitability.
Balance Sheet
78
Positive
The balance sheet is solid with a low debt-to-equity ratio of 0.05, indicating low leverage and financial stability. The return on equity is impressive at 36.37%, showcasing effective use of equity to generate profits. The equity ratio stands at 61.41%, suggesting a strong equity base relative to total assets. Overall, the balance sheet reflects financial stability and efficient equity utilization.
Cash Flow
72
Positive
Cash flow analysis shows a significant improvement in free cash flow growth at 20.27% TTM, indicating enhanced cash generation capabilities. The operating cash flow to net income ratio is moderate at 0.16, while the free cash flow to net income ratio is 0.44, suggesting room for improvement in cash conversion efficiency. Overall, the cash flow statement indicates positive cash flow growth but highlights potential areas for enhancing cash efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.40B6.79B4.19B2.68B3.62B3.38B
Gross Profit5.53B5.11B2.99B1.70B2.36B2.19B
EBITDA808.01M752.09M676.04M268.88M404.70M403.95M
Net Income904.16M781.21M461.10M147.10M338.89M203.46M
Balance Sheet
Total Assets3.95B3.60B3.13B3.15B2.27B2.22B
Cash, Cash Equivalents and Short-Term Investments799.88M732.71M914.50M1.17B157.26M174.24M
Total Debt300.83M111.67M165.57M728.20M285.04M544.10M
Total Liabilities1.45B1.36B1.10B1.44B1.32B1.64B
Stockholders Equity2.43B2.19B2.01B1.71B949.98M578.95M
Cash Flow
Free Cash Flow473.06M304.38M657.69M-23.51M269.46M124.56M
Operating Cash Flow715.30M546.95M746.16M36.56M335.19M265.97M
Investing Cash Flow-74.30M-187.03M-457.49M-66.78M-55.29M-6.95M
Financing Cash Flow-556.10M-595.67M-737.21M1.03B-289.56M-239.93M

Shanghai Chicmax Cosmetics Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price91.85
Price Trends
50DMA
95.17
Negative
100DMA
85.59
Positive
200DMA
66.41
Positive
Market Momentum
MACD
-0.50
Positive
RSI
38.44
Neutral
STOCH
14.33
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2145, the sentiment is Neutral. The current price of 91.85 is below the 20-day moving average (MA) of 95.56, below the 50-day MA of 95.17, and above the 200-day MA of 66.41, indicating a neutral trend. The MACD of -0.50 indicates Positive momentum. The RSI at 38.44 is Neutral, neither overbought nor oversold. The STOCH value of 14.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2145.

Shanghai Chicmax Cosmetics Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$3.17B14.946.65%5.55%9.72%-10.15%
73
Outperform
$31.94B12.9310.69%5.51%-3.48%-24.11%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
HK$39.80B39.3639.62%2.38%20.78%18.37%
60
Neutral
HK$42.72B16.9829.64%1.68%36.70%22.26%
47
Neutral
HK$17.94B-6.08%4.59%2.79%-170.67%
41
Neutral
$1.08B-12.38%39.29%-71.82%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
88.85
54.13
155.90%
HK:1044
Hengan International Group Co
27.66
5.23
23.32%
HK:0157
Natural Beauty Bio-Technology
0.54
0.04
8.00%
HK:6601
Cheerwin Group Limited
2.31
0.31
15.33%
HK:2367
Giant Biogene Holding Co. Ltd.
38.62
-13.14
-25.39%
HK:6993
Blue Moon Group Holdings Ltd.
3.05
0.16
5.54%

Shanghai Chicmax Cosmetics Co., Ltd. Class H Corporate Events

Shanghai Chicmax Announces Fourth Round of RSU Grants to Employees
Sep 30, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced the fourth round of granting Restricted Share Units (RSUs) to five employees, totaling 51,130 RSUs, which represents 0.01% of the company’s total shares. This move is intended to recognize and incentivize the employees’ past and expected future contributions to the company’s growth and success, with a vesting period of less than 12 months and performance targets set for eligibility.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$114.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Declares Interim Dividend for 2025
Sep 25, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced an interim cash dividend of RMB 0.5 per share for the six months ending June 30, 2025, with a corresponding payment in Hong Kong dollars. The announcement includes details on withholding tax rates applicable to different categories of shareholders, reflecting the company’s compliance with international tax treaties. This dividend declaration is part of the company’s ongoing commitment to returning value to its shareholders and may influence investor sentiment positively.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$114.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Approves Key Resolutions at 2025 EGM
Sep 25, 2025

Shanghai Chicmax Cosmetics Co., Ltd. announced the results of its second extraordinary general meeting for 2025, where all proposed resolutions were approved. These included the payment of an interim dividend, amendments to the Articles of Association, and the appointment of new directors. The approval of these resolutions reflects strong shareholder support and is likely to impact the company’s governance structure and shareholder returns positively.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$114.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Announces Board Composition and Roles
Sep 25, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced the composition of its board of directors, highlighting the roles and functions of each member. The board includes executive directors, an employee representative director, and independent non-executive directors, with specific assignments to various board committees. This announcement provides clarity on the governance structure and could impact the company’s strategic direction and stakeholder confidence.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$114.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Cosmetics Announces Key Resolutions for 2025 EGM
Sep 9, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced that it will hold its second extraordinary general meeting in 2025 to discuss several key resolutions. These include the approval of an interim dividend, amendments to governance policies, and the appointment of an executive director. Additionally, the company is considering the abolition of its Supervisory Committee and changes to its Articles of Association and procedural rules, which could impact its corporate governance structure and operational efficiency.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$109.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Clarifies Lease Agreement Ownership Details
Sep 5, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced a supplemental disclosure regarding its lease agreements with Shanghai Tianyu Shihong Enterprise Development Co., Ltd. The announcement clarifies the ownership structure of the landlord, identifying the ultimate beneficial owners as independent third parties, which may impact stakeholders’ understanding of the company’s operational transparency.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$109.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Reports Strong H1 2025 Results with KANS Leading the Market
Aug 28, 2025

Shanghai Chicmax Cosmetics Co., Ltd. reported a significant financial performance for the first half of 2025, with a 17.3% increase in revenue and a 34.7% rise in profit compared to the same period in 2024. The company announced an interim dividend of RMB0.5 per share, pending shareholder approval. KANS, one of its leading brands, maintained its top position in the beauty industry on the Douyin platform, achieving notable success with new product launches and strategic social media campaigns.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$104.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Secures New Lease for Research Expansion
Aug 28, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has entered into lease agreements with Shanghai Tianyu Shihong Enterprise Development Co., Ltd. for premises in Shanghai, intended for office and research purposes from February 2026 to February 2035. This strategic move aligns with the company’s goal to enhance its research capabilities and strengthen its position as a leader in the cosmetics industry, reflecting a commitment to operational growth and shareholder interests.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$104.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Announces Interim Dividend for H1 2025
Aug 28, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced an interim dividend of RMB 0.5 per share for the first half of 2025, with the payment date set for October 28, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may influence its market positioning by demonstrating financial stability and confidence in its future operations.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$104.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Cosmetics Announces Board Reshuffle to Strengthen Governance
Aug 28, 2025

Shanghai Chicmax Cosmetics Co., Ltd. announced several changes to its board of directors, including the appointment of Mr. Sun Hao as the secretary to the board, the resignation of Ms. Li Hanqiong as a non-executive director, and the proposed appointment of Ms. Zhou Wei as an executive director. These changes are expected to enhance the company’s corporate governance and strategic management capabilities, with Mr. Sun bringing extensive experience in corporate management and regulatory compliance, and Ms. Zhou contributing her expertise in strategic and operational management.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$104.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Cosmetics Announces Board Composition and Roles
Aug 28, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The announcement also details the roles and functions of the directors within various board committees, reflecting the company’s governance structure and strategic oversight.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$104.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Schedules Board Meeting to Review Interim Results
Aug 18, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced a board meeting scheduled for August 28, 2025, to discuss and approve the interim results for the first half of 2025. The meeting will also consider the recommendation of an interim dividend, reflecting the company’s ongoing financial strategies and potential benefits for stakeholders.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$62.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Projects Strong Revenue and Profit Growth for H1 2025
Aug 5, 2025

Shanghai Chicmax Cosmetics Co., Ltd. has announced a positive profit alert, expecting a significant increase in both revenue and profit for the first half of 2025 compared to the same period in 2024. This growth is attributed to the success of its all-channel and multi-category strategy, particularly through its KANS and newpage brands, indicating strong market positioning and potential positive implications for stakeholders.

The most recent analyst rating on (HK:2145) stock is a Buy with a HK$62.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025